|
|
Article: IMS HEALTH Reports 14.9 Percent Growth in U.S. Prescription Sales to $145 Billion in 2000.
- Article from:
- Business Wire
- Article date:
- May 31, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business/Health & Science Editors
WESTPORT, Conn--(BW HealthWire)--May 31, 2001
Cholesterol reducers lead therapeutic classes with U.S. sales of
$9 billion; Prilosec leads in prescription product sales
IMS HEALTH (NYSE: RX) today reported that U.S. prescription drug sales grew 14.9 percent to $145 billion in 2000, compared with $126 billion in sales the previous year.
Prescription product sales data are derived from IMS HEALTH's Retail and Provider Perspective(TM) service and reflect wholesale prices. IMS HEALTH is the world's leading provider of information solutions to the pharmaceutical and healthcare industries.
...